Carmell Therapeutics is focused on improving platelet-rich plasma therapy by plasticizing screened blood plasma to help treatments better stick to tissues while preserving natural growth factors. The company has used the method to develop bone putty treatments that are being evaluated in clinical trials in South Africa.

Full Story:

Related Summaries